Clinical trials
Productivity clinical trials
Below are recruiting productivity clinical trials, each written for real people, not researchers. We’re tracking 438 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07534982Recruiting
Watchful waiting vs. medication for tissue after early abortion
This study compares two approaches for managing retained pregnancy tissue (leftover tissue in the uterus after a medical abortion): waiting to see if your body passes it naturally versus taking medication to help remove it. The goal is to find out which approach works better and is safer for patients.
Kfar SabaAges 18–45 - NCT06984406Recruiting
Beet product for kidney protection during heart procedure
This trial tests a beet-derived food product (a natural source of nitrate) to see if it can help prevent kidney damage caused by the contrast dye used during a heart procedure called PCI. It is designed for people who already have a higher risk of this kidney problem.
MoscowAges 18 years+ - NCT07421895Recruiting
Study on retained tissue after pregnancy
This study follows patients with retained products of conception (tissue left in the uterus after a pregnancy) to see how they are managed in real-world medical practice. You may join if an ultrasound shows a tissue area of at least half a centimeter.
Changsha, HunanAges 18–45 - NCT07002112RecruitingPhase 1
A trial of a dual-target CAR-T therapy for blood cancers
This trial tests a new treatment that uses a virus to make your own immune cells attack two targets on cancer cells. It is for people with B-cell blood cancers that have come back or not responded to other treatments.
Hefei, AnhuiAges 18 years+ - NCT05757245RecruitingPhase 1
Safety and effectiveness of GMCN-508A for transfusion-dependent alpha thalassemia
This Phase 1 study tests a new medicine (GMCN-508A) to see how safe it is and whether it can help people with transfusion-dependent alpha thalassemia. Participants are also expected to follow a treatment plan that includes stem cell transplantation preparation.
Nanning, GuangxiAges 5–35 - NCT06382948RecruitingPhase 3
Elacestrant and everolimus for ESR1-mutant advanced breast cancer
This trial tests a new combination of two oral targeted therapy pills (elacestrant and everolimus) for people with a specific type of advanced breast cancer. It is for those whose cancer has an ESR1 mutation and has stopped responding to CDK4/6 inhibitors and hormone therapy.
InnsbruckAges 18 years+ - NCT07212803RecruitingPhase 4
Energy drinks study for young healthy adults
This study looks at how energy drinks affect your heart. It compares the effects of two different energy drinks on heart rate and other heart measures. You will have several short visits where you drink an energy drink and get your heart checked.
Stockton, CaliforniaAges 18–40 - NCT04804332Recruiting
Hysteroscopy to remove leftover tissue after miscarriage
This trial studies the best way to remove leftover pregnancy tissue after a first-trimester miscarriage. It compares approaches guided by a camera procedure in the uterus to see which helps most, especially for people who want to get pregnant again soon.
GhentAges 18–39 - NCT07142668Recruiting
How cigarette cost and availability affect tobacco buying
This study looks at how changing cigarette prices and availability affects what and how much tobacco people buy. It may help inform future policies that aim to reduce smoking.
Buffalo, New YorkAges 21 years+ - NCT07728695RecruitingPhase 1/Phase 2
Cannabis product for gynecologic pain study
This trial tests a new cannabis-based product to see if it helps with gynecologic pain (like endometriosis). It looks at how the product works and whether it is safe and effective.
Belmont, MassachusettsAges 21 years+ - NCT06988371Enrolling by invitation
Study on smoking habits in a simulated tobacco marketplace
This study looks at how people who smoke occasionally or daily choose and use cigarettes in a simulated online marketplace. It may help researchers understand buying and smoking behaviors better.
Lexington, KentuckyAges 18 years+ - NCT07721883Recruiting
Social media and tobacco use in teens
This study looks at how social media affects teens' interest in tobacco products like e-cigarettes and vapes. Researchers want to talk with high school students to understand these influences and help prevent tobacco use.
Los Angeles, CaliforniaAges 14–17 - NCT07076043RecruitingPhase 4
HIV prevention for young women getting reproductive health care
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
Thika, Kiambu CountyAges 18–30 - NCT07713706Enrolling by invitation
Brain activity study for speech production
This study looks at how the brain stops speech, using electrical recordings taken during your already-planned epilepsy monitoring. It may help understand speech control.
Pittsburgh, PennsylvaniaAges 8–26 - NCT04073420Recruiting
Cardiac surgery registry to track Medtronic device outcomes
This registry collects real-world information from people who have had—or plan to have—an eligible Medtronic cardiac surgery device. It aims to better understand how these treatments do over time and help guide future care.
Marietta, GeorgiaAges Any age - NCT04339036RecruitingPhase 2
CapTem plus Y-90 for liver-spread neuroendocrine tumors
This Phase 2 study tests whether combining capecitabine/temozolomide (“CapTem”) with Y-90 treatment can shrink neuroendocrine tumor (NET) spread in the liver. It may help people whose tumor is mostly in the liver and cannot be fully removed with surgery.
La Jolla, CaliforniaAges 18 years+ - NCT04588077RecruitingPhase 4
Two-dose vs three-dose hepatitis B vaccine for cirrhosis
This study compares giving the hepatitis B vaccine in 2 doses versus 3 doses for people with cirrhosis who do not yet have protection against hepatitis B. It may help your care team choose the schedule most likely to build lasting immunity.
Baltimore, MarylandAges 18 years+ - NCT04995003RecruitingPhase 1
HER2 CAR T plus pembrolizumab for advanced HER2 sarcoma
This Phase 1 study tests a personalized immune-cell treatment (HER2 CAR T cells) given with an immune “checkpoint” medicine (pembrolizumab or another checkpoint blocker) to shrink advanced HER2-positive sarcoma. It may help patients whose cancer is progressing or coming back after prior treatment.
Houston, TexasAges 1–25 - NCT05046600Recruiting
Hand and wrist implant registry for eligible adult patients
This registry collects information about people who need hand or wrist surgery using specific Arthrex implants. It helps the company and doctors learn how these implants are used and how patients do during healing.
Phoenix, ArizonaAges 18 years+ - NCT05085067Recruiting
Gel treatment to help prevent scar tissue after pregnancy tissue removal
This study tests whether an injected gel helps prevent scar tissue from forming again after a procedure to remove leftover pregnancy tissue inside the uterus. If you qualify, you may receive the gel as part of a randomized trial to see if it lowers the chance of re-adhesions (re-forming tissue sticking).
Beijing, Beijing MunicipalityAges 18–45 - NCT05198323RecruitingPhase 2
Study drug for people with stroke undergoing clot removal
This Phase 2 trial tests whether the study medicine (LT3001) is safe and improves outcomes for people with an acute ischemic stroke who are getting a procedure to remove a clot (EVT). It aims to help certain patients who have a specific brain scan pattern soon after stroke symptoms start.
Chattanooga, TennesseeAges 18–90 - NCT05238285Recruiting
Study of nonverbal sounds and body responses
This study records nonverbal sounds (like voice and breathing without words) and measures how your body responds. It may help researchers understand links between sound production and physical signals.
Saint-EtienneAges 18–80 - NCT05281809RecruitingPhase 2
CAR T-cell therapy made locally for B-cell blood cancers
This Phase 2 trial tests a locally manufactured CAR T-cell treatment for certain B-cell lymphomas and B-ALL that have limited treatment options left. It may help your immune system attack cancer cells that carry the CD19 marker, potentially as a bridge to transplant for some patients.
Pittsburgh, PennsylvaniaAges 18–79 - NCT05584007RecruitingPhase 3
Choosing the best antibiotic length for leg cellulitis
This Phase 3 study compares 5 days versus 7 days of antibiotic treatment for new leg cellulitis (skin infection). It may help you get the right treatment duration while keeping side effects and recovery in mind.
SouthamptonAges 18 years+
Hear when a new Productivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for productivity?
- Yes. Clin2 currently lists 438 recruiting productivity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a productivity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a productivity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.